首页> Oncology: International Journal of Cancer Research and Treatment> A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer

A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer

导出原文传递

翻译打印收藏纠错

第一作者： Rie Kondo

作者： Rie Kondo ^[1] ; Satoshi Watanabe ^[2] ; Satoshi Shoji ^[3] ; Kosuke Ichikawa ^[4] ; Tetsuya Abe ^[5] ; Junko Baba ^[6] ; Junta Tanaka ^[7] ; Hiroki Tsukada ^[8] ; Masaki Terada ^[9] ; Kazuhiro Sato ^[10] ; Yoshie Maruyama ; Masato Makino ; Akira Hirata ; Hiroshi Tanaka ; Toshiyuki Koya ; Hirohisa Yoshizawa ; Toshiaki Kikuchi

作者单位： Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of ^[1] Department of Respiratory Medicine, Nishi-Niigata Chuo National Hospital, Niigata, Japan ^[2] Department of Respiratory Medicine, Niigata Medical Center, Niigata, Japan ^[3] Department of Respiratory Medicine, Tsuruoka Municipal Shonai Hospital, Tsuruoka, Japan ^[4] Department of Respiratory Medicine, Nagaoka Red Cross Hospital, Nagaoka, Japan ^[5] Department of Internal Medicine, Tsubame Rosai Hospital, Tsubame, Japan ^[6] Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan ^[7] Department of Respiratory Medicine, Saiseikai Niigata Daini Hospital, Niigata, Japan ^[8] Department of Respiratory Medicine, Niigata City General Hospital, Niigata, Japan ^[9] Department of Internal Medicine, Niigata Prefectural Shibata Hospital, Shibata, Japan ^[10]

关键词 Refractory relapse Sensitive relapse Small-cell lung cancer Irinotecan Phase II study

发布时间 2019-02-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交